|
US2008286313A1
|
|
Peptide Vaccines for the Treatment of Cancers
|
|
US2008254445A1
|
|
Prognosis in Cancer Patients Vaccinated with a Cancer Antigen Peptide-Associated Agent
|
|
AU2002349543A1
|
|
Tumor antigens
|
|
CA2471735A1
|
|
Desensitizers
|
|
AU2749802A
|
|
Tumor antigen
|
|
WO0111044A1
|
|
Tumor antigen
|
|
CA2316396A1
|
|
Tumor antigen protein, gene thereof, and utilization thereof
|
|
EP0911397A1
|
|
Tumor antigen proteins, genes thereof, and tumor antigen peptides
|
|
KR20000016430A
|
|
Tumor antigen proteins, genes thereof, and tumor antigen peptides
|
